Trauma induced clotting factor depletion in severely injured children: a single center observational study.
Children
Clotting factors
Coagulation
Coagulopathy
Trauma
Journal
World journal of emergency surgery : WJES
ISSN: 1749-7922
Titre abrégé: World J Emerg Surg
Pays: England
ID NLM: 101266603
Informations de publication
Date de publication:
06 05 2020
06 05 2020
Historique:
received:
31
03
2020
accepted:
22
04
2020
entrez:
8
5
2020
pubmed:
8
5
2020
medline:
9
3
2021
Statut:
epublish
Résumé
Coagulopathy following severe trauma contributes significantly to mortality. Impaired clotting factors have been observed in adult trauma patients, but in pediatric trauma victims their activity has not yet been investigated. Sixteen pediatric trauma patients were evaluated according to the ISS and assigned to two cohorts. An additional control group (CO; n = 10) was formed. Routine coagulation parameters and the soluble clotting factors (F) were tested. Nonparametric data was analyzed using the Mann-Whitney U test. Results are reported as median and interquartile range. The ISS of severely (SI, n = 8) and mildly (MI, n = 8) injured children differed significantly (25 [19-28] vs. 5 [4-6]; p < 0.001). INR was elevated in the SI cohort only when compared to the CO (1.21 [1.04-1.58] vs. 0.96 [0.93-1.00]; p = 0.001). Differences between SI and MI were found for FII (67 [53-90] vs. 82 [76-114] %; p = 0.028), FV (76 [47-88] vs. 92 [82-99] %; p = 0.028), and FXIII (67 [62-87] vs. 90 [77-102] %; p = 0.021). Comparison of the SI with the CO (FII 122 [112-144] %; p < 0.001; FV 123 [100-142] %; p = 0.002; and FXIII 102 [79-115] %; p = 0.006) also revealed a reduction in the activity of these factors. Furthermore, fibrinogen (198 [80-242] vs. 296 [204-324] mg/dl; p = 0.034), FVII (71 [63-97] vs. 114 [100-152] %; p = 0.009), FIX (84 [67-103] vs. 110 [90-114] %; p = 0.043), and FX (70 [61-85] vs. 122 [96-140] %; p = 0.001) were reduced in the SI in comparison with the CO. Finally, FVIII was considerably, yet not significantly, increased in both patient cohorts (235 [91-320] % and 197 [164-238] %, respectively). This study proves that children suffer a depletion of clotting factors following severe injury which basically reflects the findings for adult trauma patients. Attempts to correct the impaired clotting factor activity could be based on a specific hemostatic therapy involving administration of coagulation factors. Nevertheless, therapeutic implications need to be investigated in future studies.
Sections du résumé
BACKGROUND
Coagulopathy following severe trauma contributes significantly to mortality. Impaired clotting factors have been observed in adult trauma patients, but in pediatric trauma victims their activity has not yet been investigated.
METHODS
Sixteen pediatric trauma patients were evaluated according to the ISS and assigned to two cohorts. An additional control group (CO; n = 10) was formed. Routine coagulation parameters and the soluble clotting factors (F) were tested. Nonparametric data was analyzed using the Mann-Whitney U test. Results are reported as median and interquartile range.
RESULTS
The ISS of severely (SI, n = 8) and mildly (MI, n = 8) injured children differed significantly (25 [19-28] vs. 5 [4-6]; p < 0.001). INR was elevated in the SI cohort only when compared to the CO (1.21 [1.04-1.58] vs. 0.96 [0.93-1.00]; p = 0.001). Differences between SI and MI were found for FII (67 [53-90] vs. 82 [76-114] %; p = 0.028), FV (76 [47-88] vs. 92 [82-99] %; p = 0.028), and FXIII (67 [62-87] vs. 90 [77-102] %; p = 0.021). Comparison of the SI with the CO (FII 122 [112-144] %; p < 0.001; FV 123 [100-142] %; p = 0.002; and FXIII 102 [79-115] %; p = 0.006) also revealed a reduction in the activity of these factors. Furthermore, fibrinogen (198 [80-242] vs. 296 [204-324] mg/dl; p = 0.034), FVII (71 [63-97] vs. 114 [100-152] %; p = 0.009), FIX (84 [67-103] vs. 110 [90-114] %; p = 0.043), and FX (70 [61-85] vs. 122 [96-140] %; p = 0.001) were reduced in the SI in comparison with the CO. Finally, FVIII was considerably, yet not significantly, increased in both patient cohorts (235 [91-320] % and 197 [164-238] %, respectively).
CONCLUSIONS
This study proves that children suffer a depletion of clotting factors following severe injury which basically reflects the findings for adult trauma patients. Attempts to correct the impaired clotting factor activity could be based on a specific hemostatic therapy involving administration of coagulation factors. Nevertheless, therapeutic implications need to be investigated in future studies.
Identifiants
pubmed: 32375899
doi: 10.1186/s13017-020-00311-6
pii: 10.1186/s13017-020-00311-6
pmc: PMC7201748
doi:
Substances chimiques
Blood Coagulation Factors
0
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
31Références
J Trauma. 1989 Oct;29(10):1416-21; discussion 1421-2
pubmed: 2810419
J Trauma. 2011 Nov;71(5 Suppl 1):S427-34
pubmed: 22071999
Anesth Analg. 2007 Dec;105(6):1610-3, table of contents
pubmed: 18042858
Pediatrics. 2012 Jun;129(6):e1533-40
pubmed: 22641758
J Trauma. 2008 Oct;65(4):748-54
pubmed: 18849786
Biomed Res Int. 2016;2016:5614086
pubmed: 27433474
Injury. 2007 Mar;38(3):298-304
pubmed: 17214989
Thromb Haemost. 2016 Jul 4;116(1):9-16
pubmed: 26988943
Am J Respir Crit Care Med. 2015 Jun 15;191(12):1395-402
pubmed: 25859890
World J Emerg Surg. 2015 Sep 22;10:43
pubmed: 26396589
Blood Coagul Fibrinolysis. 2001 Jun;12(4):229-36
pubmed: 11460005
Br J Haematol. 2004 Apr;125(1):69-73
pubmed: 15015971
Shock. 2013 May;39(5):421-6
pubmed: 23591559
J Trauma Acute Care Surg. 2019 Sep;87(3):582-589
pubmed: 31136528
Dtsch Arztebl Int. 2009 Oct;106(41):664-8
pubmed: 19946431
J Trauma Acute Care Surg. 2013 May;74(5):1223-9; discussion 1229-30
pubmed: 23609271
J Trauma. 2003 Jul;55(1):39-44
pubmed: 12855879
Anesth Analg. 2013 Aug;117(2):314-21
pubmed: 23780419
BMC Pediatr. 2014 Jul 30;14:194
pubmed: 25074319
Crit Care Med. 2005 Sep;33(9):1946-52
pubmed: 16148464
J Trauma Acute Care Surg. 2016 Jul;81(1):34-41
pubmed: 26886002
Lancet. 2009 Sep 12;374(9693):881-92
pubmed: 19748397
Pediatr Crit Care Med. 2012 May;13(3):273-7
pubmed: 21926654
J Neurosurg Anesthesiol. 2001 Jan;13(1):13-8
pubmed: 11145472
J Trauma. 2011 Nov;71(5 Suppl 1):S435-40
pubmed: 22072000
J Trauma Acute Care Surg. 2012 Jul;73(1):13-9
pubmed: 22743367
Ann Surg. 2006 Sep;244(3):371-80
pubmed: 16926563
J Pediatr Surg. 2014 Aug;49(8):1295-9
pubmed: 25092093
Pediatr Crit Care Med. 2009 Mar;10(2):e22-6
pubmed: 19265363
Infect Dis Clin North Am. 2011 Sep;25(3):653-68, x
pubmed: 21896365
Crit Care. 2011;15(6):R272
pubmed: 22087841
J Trauma Acute Care Surg. 2018 Jul;85(1):12-17
pubmed: 29443859
J Trauma. 2007 Dec;63(6):1338-46; discussion 1346-7
pubmed: 18212658
Thromb Haemost. 2008 Feb;99(2):416-26
pubmed: 18278194
Transfusion. 2012 Jun;52(6):1228-36
pubmed: 22128884
Thromb Haemost. 2000 Aug;84(2):216-22
pubmed: 10959692
J Trauma Acute Care Surg. 2013 Jul;75(1 Suppl 1):S40-7
pubmed: 23778510
Pediatrics. 2009 Mar;123(3):1066-72
pubmed: 19255041
J Surg Res. 2017 Jun 15;214:216-220
pubmed: 28624047
Surgery. 2018 Apr;163(4):827-831
pubmed: 29248181
Crit Care. 2011;15(2):R83
pubmed: 21375741
J Pediatr. 2012 Feb;160(2):204-209.e3
pubmed: 21925679
Thromb Res. 2007;120(1):29-37
pubmed: 16887171
Anaesthesia. 2017 Nov;72(11):1317-1326
pubmed: 28542848
Semin Thromb Hemost. 1995;21(4):341-56
pubmed: 8747697
J Trauma. 2003 Jun;54(6):1127-30
pubmed: 12813333
Shock. 2014 Jun;41(6):476-490
pubmed: 24569507
Crit Care Med. 2011 Dec;39(12):2652-8
pubmed: 21765358
Pediatr Crit Care Med. 2012 Jul;13(4):455-60
pubmed: 22422166
Lab Med. 2017 Nov 8;48(4):295-313
pubmed: 29126301